The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis

Arthritis and Rheumatism

Volumn 54, Issue 10, 2006, Pages 3221-3232

  Koreny, Tamas ^a   Tunyogi Csapó, Miklós ^a   Gál, Istvan ^b   Vermes, Csaba ^a   Jacobs, Joshua J ^c   Glant, Tibor T ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Kenezy Teaching Hospital   (Hungary)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CHEMOKINE; COLONY STIMULATING FACTOR 1; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BONE MARROW CELL; BONE REMODELING; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; MALE; MULTINUCLEAR CELL; OSTEOCLAST; OSTEOLYSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTHESIS; PROSTHESIS FAILURE; PROTEIN EXPRESSION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; RIBONUCLEASE PROTECTION ASSAY; STAINING; STIMULUS RESPONSE; SYNOVIUM; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; BONE RESORPTION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KNEE PROSTHESIS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; OSTEOCLASTS; OSTEOLYSIS; OSTEOPROTEGERIN; PHAGOCYTOSIS; RANK LIGAND; RNA, MESSENGER; TITANIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750287806     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22134     Document Type: Article

References (50)

1. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neill DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 1983;65:575-84.
2. Santavirta S, Konttinen YT, Bergroth V, Eskola A, Tallroth K, Lindholm TS. Aggressive granulomatous lesions associated with hip arthroplasty: immunopathological studies. J Bone Joint Surg Am 1990;72:252-8.
3. Goodman SB, Knoblich G, O'Connor M, Song Y, Huie P, Sibley R. Heterogeneity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses. J Biomed Mater Res 1996;31:421-8.
4. Glant TT, Jacobs JJ, Mikecz K, Yao J, Chubinskaya S, Williams JM, et al. Particulate-induced, prostaglandin- and cytokine-mediated bone resorption in an experimental system and in failed joint replacements. Am J Ther 1996;3:27-41.
5. Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT. Osteolysis: basic science. Clin Orthop 2001;393:71-7.
6. Friedman RJ, Black J, Galante JO, Jacobs JJ, Skinner HB. Current concepts in orthopaedic biomaterials and implant fixation. J Bone Joint Surg 1993;75:1086-109.
7. Glant TT, Jacobs JJ, Molnar G, Shanbhag AS, Valyon M, Galante JO. Bone resorption activity of particulate-stimulated macrophages. J Bone Miner Res 1993;8:1071-9.
8. Blaine TA, Rosier RN, Puzas JE, Looney RJ, Reynolds PR, Reynolds SD, et al. Increased levels of tumor necrosis factor-α and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am 1996;78:1181-92.
9. Pioletti DP, Kottelat A. The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. Biomaterials 2004;25:5803-8.
10. Granchi D, Amato I, Battistelli L, Ciapetti G, Pagani S, Avnet S, et al. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials 2005;26:2371-9.
11. Yao J, Cs-Szabo G, Jacobs JJ, Kuettner KE, Glant TT. Suppression of osteoblast function by titanium particles. J Bone Joint Surg Am 1997;79:107-12.
12. Roebuck KA, Vermes C, Carpenter LR, Fritz EA, Ramesh N, Glant TT. Down-regulation of procollagen α1[I] messenger RNA by titanium particles correlates with nuclear factor κB (NF-κB) activation and increased Rel A and NF-κB1 binding to the collagen promoter. J Bone Miner Res 2001;16:501-10.
13. Vermes C, Roebuck KA, Chandrasekaran R, Dobai JG, Jacobs JJ, Glant TT. Particulate wear debris activates protein tyrosine kinases and nuclear factor-κ B which downregulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 2000;15:1756-65.
14. Yao J, Glant TT, Lark MW, Mikecz K, Jacobs JJ, Hutchinson NI, et al. The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particles. J Bone Miner Res 1995;10:1417-27.
15. Maloney WJ, Smith RL, Castro F, Schurman DJ. Fibroblast response to metallic debris in vitro: enzyme induction, cell proliferation, and toxicity. J Bone Joint Surg Am 1993;75:835-44.
16. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT. Effects of particles on fibroblast proliferation and bone resorption in vitro. Clin Orthop 1997;342:205-17.
17. Sakai H, Jingushi S, Shuto T, Urabe K, Ikenoue T, Okazaki K, et al. Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells. Ann Rheum Dis 2002;61:103-9.
18. Wei X, Zhang X, Zuscik MJ, Drissi MH, Schwarz EM, O'Keefe RJ. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J Bone Miner Res 2005;20:1136-48.
19. Mandelin J, Li TF, Hukkanen M, Liljestrom M, Salo J, Santavirta S, et al. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-κB ligand, osteoprotegerin, and cathepsin K. J Rheumatol 2005;32:713-20.
20. Sabokbar A, Itonaga I, Sun SG, Kudo O, Athanasou NA. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J Orthop Res 2005;23:511-9.
21. Ragab AA, van de Motter R, Lavish SA, Goldberg VM, Ninomiya JT, Carlin CR, et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999;17:803-9.
22. Chiba J, Schwendeman LJ, Booth REJr, Crossett LS, Rubash HE. A biochemical, histologic, and immunohistologic analysis of membranes obtained from failed cemented and cementless total knee arthroplasty. Clin Orthop Relat Res 1994;229:114-24.
23. He W, Pelletier JP, Martel-Pelletier J, Laufer S, Di Battista JA. Synthesis of interleukin 1β, tumor necrosis factor-α, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with anti-inflammatory cytokines. J Rheumatol 2002;29:546-53.
24. Moller B, Kukoc-Zivojnov N, Kessler U, Rehart S, Kaltwasser JP, Hoelzer D, et al. Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis. Rheumatology (Oxford) 2001;40:302-9.
25. Vermes C, Chandrasekaran R, Dobai J, Jacobs JJ, Andersson GB, An H, et al. The combination of pamidronate and calcitriol reverses particle- and TNF-α - induced altered functions of bone-marrow-derived stromal cells with osteoblastic phenotype. J Bone Joint Surg Br 2004;86:759-70.
26. Kaplan CD, O'Neill SK, Koreny T, Czipri M, Finnegan A. Development of inflammation in proteoglycan-induced arthritis is dependent on FcγR regulation of the cytokine/chemokine environment. J Immunol 2002;169:5851-9.
27. Czipri M, Otto JM, Cs-Szabo G, Kamath RV, Vermes C, Firneisz G, et al. Genetic rescue of chondrodysplasia and the perinatal lethal effect of cartilage link protein deficiency. J Biol Chem 2003;278:39214-23.
28. Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, et al. Evidence for a role of a tumor necrosis factor-α (TNF-α)- converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 1999;274:13613-8.
29. Horiki M, Nakase T, Myoui A, Sugano N, Nishii T, Tomita T, et al. Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab 2004;22:346-51.
30. Manlapaz M, Maloney WJ, Smith RL. In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. J Orthop Res 1996;14:465-72.
31. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β. J Rheumatol 1997;24:1253-9.
32. Santavirta S, Xu JW, Hietanen J, Ceponis A, Sorsa T, Kontio R, et al. Activation of periprosthetic connective tissue in aseptic loosening of total hip replacements. Clin Orthop 1998;352:16-24.
33. Konttinen YT, Saari H, Santavirta S, Antti-Poika I, Sorsa T, Nykanen P, et al. Synovial fibroblasts. Scand J Rheumatol Suppl 1988;76:95-103.
34. Goodman SB, Huie P, Song Y, Schurman D, Maloney W, Woolson S, et al. Cellular profile and cytokine production at prosthetic interfaces: study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br 1998;80:531-9.
35. Ninomiya JT, Struve JA, Stelloh CT, Toth JM, Crosby KE. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts. J Orthop Res 2001;19:621-8.
36. Neumann E, Gay S, Muller-Ladner U. The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: new insights from animal models [editorial]. Arthritis Rheum 2005;52:2960-7.
37. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000;2:361-7.
38. Suzuki J, Ikeda T, Kuroyama H, Seki S, Kasai M, Utsuyama M, et al. Regulation of osteoclastogenesis by three human RANKL isoforms expressed in NIH3T3 cells. Biochem Biophys Res Commun 2004;314:1021-7.
39. Lee JM, Salvati EA, Betts F, DiCarlo EF, Doty SB, Bullough PG. Size of metallic and polyethylene debris in failed cemented total hip replacements. J Bone Joint Surg Br 1992;74:380-4.
40. Shanbhag AS, Jacobs JJ, Glant TT, Gilbert JL, Black J, Galante JO. Composition and morphology of wear debris in failed uncemented total hip replacement arthroplasty. J Bone Joint Surg Br 1994;76:60-7.
41. Maloney WJ, Smith RL, Schmalzried TP, Chiba J, Huene D, Rubash H. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am 1995;77:1301-10.
42. Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 2002;4:281-9.
43. Sabokbar A, Kudo O, Athanasou NA. Two distinct cellular mechanisms of osteoclast formation and bone resorption in pedprosthetic osteolysis. J Orthop Res 2003;21:73-80.
44. Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor κB, osteoprotegerin, and receptor activator of nuclear factor κB ligand. Arthritis Rheum 2004;50:3831-43.
45. Jimi E, Aoki K, Saito H, D'Acquisto F, May MJ, Nakamura I, et al. Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med 2004;10:617-24.
46. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 1999;190:293-8.
47. Henriksen K, Karsdal M, Delaisse JM, Engsig MT. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J Biol Chem 2003;278:48745-53.
48. Min JK, Kim YM, Kim YM, Kim EC, Gho YS, Kang IJ, et al. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-κB (RANK) in endothelial cells: concomitant increase of angiogenic responses to RANK ligand. J Biol Chem 2003;278:39548-57.
49. Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br 2001;83:902-11.
50. Mandelin J, Li TF, Liljestrom M, Kroon ME, Hanemaaijer R, Santavirta S, et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg Br 2003;85:1196-201.